Sponsor Check › Exokinetics › Issuer
Limited Liability Company · organized in DELAWARE · formed 2024 · NASHVILLE, TN · SEC CIK 2050017
Part of sponsor group: Exokinetics (2 issuers, 3 filings) · grouped because: shared people · confidence 100% · Not the same sponsor? Request a correction
Data last updated: Oct 23, 2026, 5:45 PM ET · Latest filing by this issuer: Oct 19, 2026 · Courts (RECAP) last checked: not yet · SEC enforcement last checked: not yet
The five facts investors ask about first. Each section states what was searched and when. Items still in human review are not shown.
Not yet searched.
Sources to be searched: CourtListener / RECAP archive (federal district courts, federal bankruptcy courts). State courts: not yet searched. PACER: not searched (RECAP only). · Search queued. Results are added automatically; check back later or follow this page to be notified.
Not yet searched.
Sources to be searched: SEC litigation releases and administrative proceedings — respondent names in the sec.gov index titles (30,205 releases, 1995-09-19 to 2026-10-23); release text is read only to confirm a candidate. Names that appear only in the body of a release are not found. State securities regulator actions: not yet searched. · Search queued. Results are added automatically; check back later or follow this page to be notified.
Not yet searched.
Sources to be searched: Federal bankruptcy courts via CourtListener / RECAP archive (federal district courts, federal bankruptcy courts). State courts: not yet searched. PACER: not searched (RECAP only). · Search queued. Results are added automatically; check back later or follow this page to be notified.
Coming soon.
What will be compared: what the sponsor says publicly (website, marketing materials, claimed profile) against what public records show — SEC Form D filings, Form ADV adviser registration, and state business records. Every comparison is reviewed by a person before it is published.
No comparisons published yet.
Sources to be compared: sponsor public claims · SEC Form D · SEC Form ADV (IAPD) · state business records · As of Oct 23, 2026, 9:13 PM ET.
0 of 2 offerings report sales commissions; 0 report finder's fees; 0 report proceeds to related persons. (includes amounts the issuer reported as estimates)
| Source | Offering (latest filing) | Sales commissions | Finder's fees | To insiders | Paid to sell it |
|---|---|---|---|---|---|
| EDGAR ↗ | Dec 30, 2024 D File 021-533594 | $0 | $0 | $0 (est.) Proceeds will be used for working capital, which may include normal compensation to executive officers. | None listed |
| EDGAR ↗ | Oct 19, 2026 D File 021-601739 | $0 | $0 | $0 (est.) Proceeds will be used for working capital, which may include normal compensation to executive officers. | None listed |
As reported by the issuer on Form D (Items 12–15), latest filing per offering. "To insiders" = gross proceeds used for payments to executive officers, directors or promoters. "—" = not reported on that filing. Amounts marked (est.) were reported as estimates.
Each filing as reported by the issuer. Open a row for the full plain-English detail.
| Filing | Form D filed Oct 19, 2026 SEC file no. 021-601739 · accession 0002050017-26-000005 |
|---|---|
| Raise progress | $10,915,000 sold of $17,500,000 offered (62%) · $6,585,000 remaining |
| Filing timing | Date of first sale: Oct 1, 2026 · Form D filed: Oct 19, 2026 (18 days after first sale) Rule: a Form D is generally due within 15 days after the first sale. Both dates are shown as reported; no conclusion is drawn. |
| Time since first sale | 23 days (0.1 years) |
| Annual amendments | Issuer reported the offering is not expected to last more than one year. Rule: an ongoing offering generally files an amendment at least annually. Dates shown as reported; no conclusion is drawn. |
| Investors | 30 total · issuer reported no non-accredited investors |
| Exemption claimed | Rule 506(b) — no general advertising; up to 35 non-accredited investors allowed |
| Minimum investment accepted | $100,000 |
| Securities offered | Equity |
| Industry / issuer size | Other Health Care · revenue range: Decline to Disclose |
| Who is paid to sell it | No sales compensation recipients listed on this filing. |
| Money to insiders | Sales commissions: $0 · Finder's fees: $0 · Proceeds to officers, directors, promoters: $0 (est.) Proceeds will be used for working capital, which may include normal compensation to executive officers. |
| Signed by | Thomas J. Harper, Jr., Chief Operating Officer (Oct 19, 2026) |
| Market context | Minimum investment: $100,000. Typical range for similar offerings: $10,000–$54,310. Offering size: $17,500,000. Typical range: $829,831–$9,999,998. Investors: 30. Typical range: 2–15. "Similar" = Other Health Care offerings claiming 506(b) filed in the last 5 years (4,189 filings); ranges are the middle half (25th–75th percentile). No ranking or score. |
| Source | This filing on SEC EDGAR ↗ · retrieved from the EDGAR daily index |
| Filing | Form D filed Dec 30, 2024 SEC file no. 021-533594 · accession 0002050017-24-000001 |
|---|---|
| Raise progress | $15,000,000 sold of $15,000,000 offered (100%) · $0 remaining |
| Filing timing | Date of first sale: Dec 20, 2024 · Form D filed: Dec 30, 2024 (10 days after first sale) Rule: a Form D is generally due within 15 days after the first sale. Both dates are shown as reported; no conclusion is drawn. |
| Time since first sale | 673 days (1.8 years) |
| Annual amendments | Issuer reported the offering is not expected to last more than one year. Rule: an ongoing offering generally files an amendment at least annually. Dates shown as reported; no conclusion is drawn. |
| Investors | 6 total · issuer reported no non-accredited investors |
| Exemption claimed | Rule 506(b) — no general advertising; up to 35 non-accredited investors allowed |
| Minimum investment accepted | $500,000 |
| Securities offered | Equity |
| Industry / issuer size | Other Health Care · revenue range: Decline to Disclose |
| Who is paid to sell it | No sales compensation recipients listed on this filing. |
| Money to insiders | Sales commissions: $0 · Finder's fees: $0 · Proceeds to officers, directors, promoters: $0 (est.) Proceeds will be used for working capital, which may include normal compensation to executive officers. |
| Signed by | Phillip H. Watts, Chief Executive Officer (Dec 30, 2024) |
| Market context | Minimum investment: $500,000. Typical range for similar offerings: $10,000–$54,310. Offering size: $15,000,000. Typical range: $829,831–$9,999,998. Investors: 6. Typical range: 2–15. "Similar" = Other Health Care offerings claiming 506(b) filed in the last 5 years (4,189 filings); ranges are the middle half (25th–75th percentile). No ranking or score. |
| Source | This filing on SEC EDGAR ↗ · retrieved from the SEC Form D bulk data set |
All Form D filings for this CIK on SEC EDGAR ↗. History: 1 new offering in the last 12 months · most recent filing Oct 19, 2026.
| Name | Relationship | Address state | On filings | Also listed on |
|---|---|---|---|---|
| DAVID S. CHERNOW | Executive Officer, Director | TN | Dec 30, 2024 → Oct 19, 2026 | — |
| MARTIN F. JACKSON | Director | TN | Dec 30, 2024 → Oct 19, 2026 | — |
| MAX BUETOW | Director | TN | Oct 19, 2026 | — |
| PHILLIP H. WATTS | Promoter Mr. Watts is no longer affiliated with the Issuer, but has served as a promoter within the past 5 years. | TN | Dec 30, 2024 → Oct 19, 2026 | — |
| ROBERT A. ORTENZIO | Director | TN | Dec 30, 2024 → Oct 19, 2026 | — |
| STANLEY M. MARKS, MD | Director | TN | Oct 19, 2026 | — |
| STEVEN CUTLER | Promoter Mr. Cutler is no longer affiliated with the Issuer, but has served as a promoter within the past 5 years. | TN | Oct 19, 2026 | — |
| THOMAS J. HARPER, JR. | Executive Officer, Promoter | TN | Oct 19, 2026 | — |
| WILLIAM B. DOWNEY | Director | TN | Oct 19, 2026 | — |
| STEVEN H. CUTLER | Executive Officer, Promoter | TX | Dec 30, 2024 | — |
| THOMAS J. HARPER | Executive Officer, Promoter | TX | Dec 30, 2024 | — |
Executive officers, directors and promoters as self-reported by the issuer. Licensed persons: FINRA BrokerCheck ↗ · SEC IAPD ↗.
No other issuers list the same related persons.
Shared address: this business address appears on filings for 13 other issuers. Stated as a count only — many addresses are shared office buildings or registered agents.
Not yet searched. Sources to be searched: SEC Investment Adviser Public Disclosure (IAPD) firm search — registered and exempt reporting advisers · Search queued. Results are added automatically; check back later.
Not yet collected. We store official links only (company website, verified via a profile claim) and the earliest archived date of the website; never personal or family accounts.
Export this report as PDF (all source links + data timestamp; members)
No corrections have been requested for this page.
The complete public-record profile for MODEL ONCOLOGY, LLC, plus the weekly new-filings list.
Only "Connect me" shares your details — with this sponsor, at a flat price we charge them, never tied to whether you invest. "Just researching" shares nothing.
Free. Tell us what's wrong and, if you can, where the correct public record is. Every request is logged with its status (received → under review → fixed / confirmed with source).
Sponsors may add a sourced explanation next to any fact on this page. Reviewed before publishing; never edits the public record.
Free. Get the "Claimed by sponsor" chip and a verified contact for corrections. Claiming never changes the public-record section.